The CT values for blood samples collected on days 4–5 post-infection from mice challenged with BTV-1RGC7 (Figure 4, Table S1) were significantly different (p < 0.05—95% confidence—Table S5) for either the mock-immunised group (mild infection—Gp1) or the group of mice immunised with VP2 of BTV-1 (protected—Gp4), when compared to the groups immunised with VP2 of BTV-4 (Gp7), VP2 of BTV-8 (Gp10), or VP5 of BTV-10 (Gp13), which all showed severe and fatal infections. This evidence concerns the gene CD36 and infection.